文献速递甲状腺疾病

甲状腺髓样癌淋巴结转移预后阈值:限制性立方样条分析

Prognostic Thresholds for Lymph Node Metastasis in Medullary Thyroid Cancer: A Restricted Cubic Splines Analysis.
PubMed 文献 · Thyroid · 2025-10-20

多变量分析显示阳性淋巴结≥8枚与癌特异性死亡风险增加相关(HR 1.54),淋巴结比率≥14%的风险更高(HR 3.308)。单中心149例验证队列中,两阈值均与无复发生存显著相关。

要点

  • 阳性淋巴结≥8枚与甲状腺髓样癌特异性死亡风险增加独立相关(HR 1.54)。
  • 淋巴结比率≥14%与癌特异性死亡风险增加相关(HR 3.308),风险增幅大于阳性淋巴结数阈值。
  • 两阈值在验证队列中均与无复发生存显著相关,淋巴结比率≥14%者5年无复发生存仅67.9%。

核心结论

  • 在人群水平数据中识别出与甲状腺髓样癌特异性死亡相关的稳健淋巴结阈值:阳性淋巴结数7.8枚和淋巴结比率13.8%。
  • 淋巴结比率≥14%较阳性淋巴结≥8枚与癌特异性死亡风险增幅更大。

研究设计与样本

  • 采用限制性立方样条Cox模型评估淋巴结比率和阳性淋巴结数与癌特异性死亡的功能关系,通过马尔可夫链蒙特卡洛和自举法估计阈值。
  • 验证队列为单中心1996-2025年149例甲状腺髓样癌患者。

主要发现

  • 推导队列平均年龄54.1岁,女性占59.1%,非西班牙裔白人占69.6%,平均肿瘤大小23.5 mm,接受淋巴结检查者中52.7%有≥1枚阳性淋巴结,5年癌特异性生存率93.3%。
  • 识别出阳性淋巴结数阈值7.8枚和淋巴结比率阈值13.8%(非线性检验P<0.001)。

临床怎么用

  • 在甲状腺髓样癌术后病理评估中,除AJCC分期定性分层外,可量化报告阳性淋巴结数和淋巴结比率。
  • 阳性淋巴结≥8枚或淋巴结比率≥14%提示癌特异性死亡和无复发生存风险较高,淋巴结比率≥14%的风险增幅更大。
  • 上述阈值可用于辅助风险分层和随访强度决策,但需结合其他临床病理因素综合判断。

局限性

  • 推导队列为回顾性SEER数据库分析,可能存在选择偏倚和未测量混杂。
  • 验证队列为单中心149例,样本量有限。
  • 原文未报告阈值在外部多中心前瞻性队列中的验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: The current American Joint Committee on Cancer medullary thyroid cancer (MTC) staging system qualitatively stratifies lymph node (LN) status based on involved LN compartments; however, American Thyroid Association guidelines note that quantitative assessment of LN metastases "should be incorporated." Several studies have proposed LN ratio (LNR) and number of positive LNs as prognostic parameters. We (1) assess whether there are prognostically significant LN thresholds, (2) estimate their association with MTC-specific mortality, and (3) appraise the identified thresholds using an institutional database. Methods: In this retrospective cohort analysis, MTC patients were abstracted from the Surveillance, Epidemiology, and End Results database (2004-20). Cox models with restricted cubic splines assessed the functional relationship of LNR and positive LN count with MTC-specific mortality. Thresholds were estimated using Markov Chain Monte Carlo and bootstrapping. Multivariable models estimated the association of the thresholds with mortality. The testing cohort comprised 149 patients with MTC at a single institution (1996-2025). Results: There were 2709 patients in the derivation cohort; 2098 (77.4%) had LNs examined. Mean patient age was 54.1 years, 59.1% were female, and 69.6% were non-Hispanic White. Mean tumor size was 23.5 mm; 52.7% of patients with LNs examined had ≥1 positive LN. The 5-year MTC-specific survival was 93.3%. Threshold values of 7.8 positive LNs and a LNR of 13.8% were identified (nonlinearity p < 0.001 for both). Adjusted analyses revealed that ≥8 positive LNs were associated with a significantly increased hazard of MTC-specific mortality (hazard ratio [HR] 1.54, confidence interval [CI]: 1.09-2.17, p = 0.014, model area under the curve [AUC] 86.7%); a LNR ≥14% was associated with a significantly increased mortality hazard (HR: 3.308, CI: 2.096-5.222, p < 0.001, model AUC: 87.9%). The thresholds were significantly associated with recurrence-free survival in the testing cohort: 5-year recurrence-free survival was 56.5% (CI: 39.5 - 70.4) for patients with ≥8 positive LNs and 90.5% (CI: 82.5 - 94.9) for <8 (log-rank p < 0.001); it was 67.9% (CI: 55 - 77.9) for patients with LNR ≥14% and 92.8% (CI: 83.6 - 97) for LNR <14 (log-rank p < 0.001). Conclusions: Using population-level data, we identified robust LN thresholds associated with MTC-specific mortality. Compared with a threshold of 8 positive LNs, a LNR threshold ≥14% was associated with a greater increase in hazard of MTC-specific mortality.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lindsay CV, Wang F, Thomas SM, et al. Prognostic Thresholds for Lymph Node Metastasis in Medullary Thyroid Cancer: A Restricted Cubic Splines Analysis. Thyroid. 2025. PMID: 41173540. doi:10.1177/10507256251388406

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。